PEXA GROUP LIMITED (PXA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

PXA

PXA - PEXA GROUP LIMITED

FNArena Sector : Real Estate
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 2.47
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$13.65

03 Feb
2026

-0.160

OPEN

$13.90

-1.16%

HIGH

$14.08

415,613

LOW

$13.60

TARGET
$17.397 27.4% upside
OTHER COMPANIES IN THE SAME SECTOR
APZ . DGH . HMC . REA . RMY . UBN .
FNARENA'S MARKET CONSENSUS FORECASTS
PXA: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx - 43.0 20.5 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 64.6 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx-43.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx393.6 M
Book Value Per Share xxxxxxxxxxxxxxx649.9
Net Operating Cash Flow xxxxxxxxxxxxxxx116.8 M
Net Profit Margin xxxxxxxxxxxxxxx-19.33 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-6.42 %
Return on Invested Capital xxxxxxxxxxxxxxx-4.97 %
Return on Assets xxxxxxxxxxxxxxx-4.15 %
Return on Equity xxxxxxxxxxxxxxx-6.42 %
Return on Total Capital xxxxxxxxxxxxxxx1.82 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx116.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx321 M
Total Debt xxxxxxxxxxxxxxx324 M
Goodwill - Gross xxxxxxxxxxxxxxx754 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx71 M
Price To Book Value xxxxxxxxxxxxxxx2.09

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx57.8 M
Capex % of Sales xxxxxxxxxxxxxxx14.68 %
Cost of Goods Sold xxxxxxxxxxxxxxx170 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx196 M
Research & Development xxxxxxxxxxxxxxx20 M
Investments - Total xxxxxxxxxxxxxxx19 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

14/01/2026

1

Buy

$17.00

24.54%

UK expansion remains the key upside for Pexa Group, but UBS notes sentiment has been dampened by Australian regulatory uncertainty. 

In that context, the broker points to two independent reports published by ARNECC highlighting high cost, complexity and limited economic benefit from IOP (interoperability). This reinforces the reasons for the Sep-24 pause and reduces the likelihood of adverse outcomes.

With ARNECC’s formal position and IPART’s draft ELNO fee report due by March, regulatory clarity is approaching, raising optimism that regulatory clouds could clear.

Buy retained for Pexa. Target trimmed to $17.00 from $17.45, mainly on a higher DCF risk-free rate in the valuation.

FORECAST
UBS forecasts a full year FY26 dividend of 0.00 cents and EPS of 24.00 cents.
UBS forecasts a full year FY27 dividend of 17.00 cents and EPS of 34.00 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

01/02/2026

1

Buy

$17.40

27.47%

Jarden remains cautiously optimistic regarding the outcome of Australian regulatory reviews, suspecting the status quo will be maintained in terms of electronic conveyancing and the IPART pricing review.

The broker retains a view that any Australian regulatory downside risk is more than offset by UK upside and retains a Buy rating for Pexa Group.

Scenario analysis signals around 17% terminal EBITDA upside if the status quo continues and the company attains 95% terminal market share. Target is $17.40.

FORECAST
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 29.40 cents.
Jarden forecasts a full year FY27 EPS of 42.60 cents.

PXA STOCK CHART